The Global Immuno-oncology Clinical Trials Market size was estimated at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13% from 2022 to 2028.
Immunotherapy is becoming increasingly available in clinical trials for early-stage cancer or as a first-line treatment option as clinical research progresses rapidly. Targeted antibodies, cancer vaccines, adoptive cell transfer, oncolytic viruses, checkpoint inhibitors, cytokines and adjuvants are all examples of cancer immunotherapy. Because they use living things to fight disease, immunotherapy is a type of biotherapy (also called biotherapy or biological response modulator (BRM) therapy). Gene therapy is an immunotherapy treatment that uses genetic engineering to improve the ability of immune cells to fight cancer.
(Get 15% Discount on Buying this Report)
A full report of Global Immuno-oncology Clinical Trials Market is available at: https://orionmarketreports.com/immuno-oncology-clinical-trials-market/93805/
Market Segments
Immuno-oncology Clinical Trials – By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Immuno-oncology Clinical Trials – By Design
- Interventional trials
- Observational trials
- Expanded access trials
Immuno-oncology Clinical Trials – By Indication
- Solid tumors
- Hematological cancer
Key Players
- ICON, Plc
- IQVIA Holdings
- BioNtech
- Covance, Inc.
- IO BIOTECH
- MEDPACE
- Exscientia
- Syneous Health
- Astrazeneca
- Novartis
Scope of the Report
The research study analyzes the global Immuno-oncology Clinical Trials industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Immuno-oncology Clinical Trials Market Report
1. What was the Immuno-oncology Clinical Trials Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Immuno-oncology Clinical Trials Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Immuno-oncology Clinical Trials Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Immuno-oncology Clinical Trials market.
- The market share of the global Immuno-oncology Clinical Trials market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Immuno-oncology Clinical Trials market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Immuno-oncology Clinical Trials market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
